3YJ-12496-38509
2 vaccinations
1 coded response
12 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 062 / CT
- Registered
- 2021-03-12
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-07
Dose 1 — Janssen/Johnson & Johnson
-
2021-03-12
Registered in v-safe
- 2021-03-12
- 2021-03-13
- 2021-03-16
- 2021-03-21
- 2021-03-28
- 2021-04-04
- 2021-04-11
- 2021-04-18
-
2021-06-06
Survey response — 3 months, dose 1MedDRA: Upper respiratory tract infection — Feeling: Good · Be unable to do your normal daily activitiesFree text: I had an upper respiratory infection that was not COVID. It lasted about a week.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-09-07
-
2021-10-01
Dose 2 — Pfizer-BioNTech
- 2021-10-31
- 2021-11-14
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-07 | Janssen/Johnson & Johnson | |
| 2 | 2021-10-01 | Pfizer-BioNTech | No |
Free text
Release 8 — 3 months, dose 1
Symptoms: I had an upper respiratory infection that was not COVID. It lasted about a week.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Upper respiratory tract infection | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release